Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint ...

Aims: Survival and response rates in metastatic colorectal cancer remain poor, despite advances in drug development. There is increasing evidence to suggest that gender-specific differences may ...

Tyrosine kinase inhibitor: a type of medication that blocks the activity of enzymes called tyrosine kinases. Partial response: a decrease in the size of a tumor or the extent of cancer in the body in ...